(firstQuint)A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004).

 This study will consist of 2 stages.

 In stage 1, adult participants will be administered a single dose of V114.

 After completion of a review of safety data from the adult cohort, stage 2 of the study will enroll infants.

 Infants will receive a 4-dose schedule of either an active comparator or 1 of 5 dose/adjuvant combinations of V114.

.

 A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)@highlight

This study is designed to assess the effect of different dose levels of pneumococcal polysaccharide and adjuvant on the safety and immunogenicity of V114 in healthy adults and infants.

